Literature DB >> 17702436

[Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland].

Grzegorz Piotr Stańczak1, Janusz Julian Stańczak, Ewa Firlag-Burkacka, Alicja Wiercińska-Drapało, Magdalena Leszczyszyn-Pynkad, Ewa Jabłonowska, Ewa Małolepsza, Andrzej Horban.   

Abstract

OBJECTIVE: HIV-1 drug resistance is becoming a growing concern. It is estimated that one out of ten newly diagnosed persons in Europe acquires HIV drug resistant strain. The aim of this study was to determine the transmission of drug resistance and identify the resistance patterns among naïve patients in Poland.
METHODS: The patients were asked to complete a brief questionnaire concerning demographic and epidemiological data. Viral load and CD4/CD8 counts were detemined before drug resistance testing. The sequencing assay was performed according to manufacturer's protocol. MAIN OBSERVATIONS: In the analysed cohort 14.7% of patients acquired HIV-1 drug resistant strains; further 9.5% were infected with strains with "possibly lowered susceptibility".
RESULTS: In all cases resistance to single class of antiretroviral drugs were identified. In the class of PIs resistance to NFV was the most common. The rates of drug resistance among NNRTIs were almost the same--about 5%. In the NRTI class the resistance to AZT and d4T was the most frequent. HIV-1 subtype B was identified in 88.8% of cases.
CONCLUSIONS: The results of this study document high transmission rate of drug resistance in Poland and justify the necessity of common DR testing in our country.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702436

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  4 in total

1.  Retrospective analysis of the HIV-1 reverse transcriptase inhibitors' resistance in Silesia, Poland.

Authors:  Joanna Smolén; Piotr Kruszyński; Jolanta Bratosiewicz-Wąsik; Adam Witor; Tomasz J Wąsik
Journal:  Med Sci Monit       Date:  2011-02

2.  HIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysis.

Authors:  Miłosz Parczewski; Magdalena Leszczyszyn-Pynka; Dorota Bander; Anna Urbanska; Anna Boroń-Kaczmarska
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

3.  Cascade of care and factors associated with virological suppression among HIV-positive persons linked to care in the Test and Keep in Care (TAK) project.

Authors:  Justyna D Kowalska; Magdalena Ankiersztejn-Bartczak; Leah Shepherd; Amanda Mocroft
Journal:  Infection       Date:  2018-05-21       Impact factor: 3.553

4.  Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.

Authors:  Justyna D Kowalska; Joanna Kubicka; Ewa Siwak; Piotr Pulik; Ewa Firląg-Burkacka; Andrzej Horban
Journal:  AIDS Res Ther       Date:  2016-01-07       Impact factor: 2.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.